T1	intervention 39 59	oral bisphosphonates
T2	location 644 650	Israel
T3	average-age 718 729	55-75 years
T5	eligibility 679 712	osteopenic and osteoporotic women
T4	eligibility 730 774	who started BP therapy between 1998 and 2012
T6	duration 823 830	3 years
T7	No-of-participants 1367 1373	11,717
T8	average-age 1384 1407	mean age = 66.87 ± 4.38
T9	outcome 1515 1546	incident cases of breast cancer
T10	outcome 1621 1660	adjusted hazard ratio for breast cancer
